PRODUCTS
Multi Plex Matrix MPM-DM0809
Indication: SKIN DiSEASES
MPM-DM0809 exhibits an anti-inflammatory effect compared to oral hydrocortisone treatment in dermatitis model.
MPM-DM0809 was tested in a dermatitis model, on keratinocytes cells and in humans to ensure non-allergenic responses (HRIPT).
MPM-DM0809 activates the TGFß pathway and maintains skin homeostasis under stress conditions such as UVB.
MPM-DM0809 exhibited no side effects associated with anti-inflammatory activities such as weight loss or immuno-suppression.
MPM-DM0809 anti-inflammatory effect is associated with inhibition of distant neutrophil infiltration.
MPM-DM0809 improves hydration and regeneration of the skin associated with psoriatic arthritis, psoriasis and atopic dermatitis.
MPM-DM0809 relieves the inflammation associated with psoriatic arthritis, psoriasis and atopic dermatitis through the Th17-pathway.
Technical Targeted Health Claim
Management of psoriatic arthritis, psoriasis and atopic dermatitis.
Inflammation level during the atopic contact dermatitis model.